BEUDAMED
    47 results · 23ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Country: France ×

    Doculyse

    Device
    EU MDR · Eu Md Class 1 ·QUIES SAS·On the market

    Anti Snoring Lozenges C

    Device
    EU MDD · Eu Md Class 1 ·QUIES SAS·On the market

    Anti Snoring Lozenges HL

    Device
    EU MDD · Eu Md Class 1 ·QUIES SAS·On the market

    Anti Snoring Oral Spray

    Device
    EU MDD · Eu Md Class 1 ·QUIES SAS·On the market

    Anti Snoring Nasal Strips L

    Device
    EU MDR · Eu Md Class 1 ·QUIES SAS·On the market·3 countries

    Anti Snoring Nasal Strips SM

    Device
    EU MDR · Eu Md Class 1 ·QUIES SAS·On the market

    Anti Snoring Nasal Spray

    Device
    EU MDD · Eu Md Class 1 ·QUIES SAS·On the market

    Docuspray

    Device
    EU MDR · Eu Md Class 1 ·QUIES SAS·On the market

    Doculyse

    Device
    EU MDR · Eu Md Class 1 ·QUIES SAS·On the market·6 countries

    BARRE DE LIT COULEUR RAL 5002 NUE

    Device
    EU MDR · Eu Md Class 1 ·ALTER ECO SANTE Sarl·On the market

    BARRE DE LIT COULEUR RAL 4006 NUE

    Device
    EU MDR · Eu Md Class 1 ·ALTER ECO SANTE Sarl·On the market

    QUIES SAS

    Importer
    🇫🇷 France

    Anti Snoring Lozenges

    Basic UDI-DI
    EU MDD · Eu Md Class 1 ·QUIES SAS·1 device

    Anti Snoring Lozenges

    Basic UDI-DI
    EU MDD · Eu Md Class 1 ·QUIES SAS·1 device

    Anti Snoring Oral Spray

    Basic UDI-DI
    EU MDD · Eu Md Class 1 ·QUIES SAS·1 device

    Anti Snoring Nasal Spray

    Basic UDI-DI
    EU MDD · Eu Md Class 1 ·QUIES SAS·1 device

    Docuspray

    Basic UDI-DI
    EU MDR · Eu Md Class 1 ·QUIES SAS·1 device

    Doculyse

    Basic UDI-DI
    EU MDR · Eu Md Class 1 ·QUIES SAS·2 devices

    Anti Snoring Nasal Strips

    Basic UDI-DI
    EU MDR · Eu Md Class 1 ·QUIES SAS·2 devices

    Medicrea, IB3D Universal Implant Inserter, Rx Only REF: A24000000

    FDA Enforcement
    Class II ·Ongoing·Medicrea International·January 21, 2026